| Biological Information | |
|---|---|
| Background Information: | Murine CXCL13 is a small cytokine protein that is selectively chemotactic for B cells belonging to both the B-1 and B-2 subsets, and carries out its effects by interacting with its chemokine receptor, CXCR5. It takes part in the formation of ectopic lymphoid tissue in chronic inflammation. Provided as 5 μg of dry powder alongside reconstitution buffer. |
| Target Class: | Chemokine |
| Family: | Chemokine Receptors |
| Target Name: | CXCL13 |
| Usage | |
| Product Type: | Recombinant Proteins |
| Application: | Drug Discovery & Development |
| Storage Conditions: | Store at ≤-20°C. Please avoid multiple freeze/thaw cycles. |
| Usage Disclaimer: | These products may be covered by issued US and/or foreign patents, patent application and subject to Limited Use Label License. Please visit discoverx.com/license for a list of products that are governed by limited use label license terms and relevant patent and trademark information. |
| Additional Information | |
| Brand: | DiscoverX |
Recombinant Murine CXCL13
Recombinant Murine CXCL13 is an agonist for CXCR5. This product is provided as 5μg of dry powder alongside reconstitution buffer.
Datasheets
92-1020 Datasheet
View Document